There have been 50 recent insider transactions recorded for Nurix Therapeutics, Inc. (NRIX), including 21 buys and 27 sells. Total insider buying was valued at $20.2M and total insider selling at $1.06M.
Notable insiders with recent activity include Ring Christine, Sands Arthur T, Hansen Gwenn. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — NRIX
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-04-02 |
Ring Christine |
Chief Legal Officer |
Informative Sell |
8,148 |
$15.24 |
$124.15K |
26,453 |
| 2026-03-02 |
Ring Christine |
Chief Legal Officer |
Informative Sell |
8,148 |
$15.44 |
$125.79K |
34,601 |
| 2026-02-10 |
Sands Arthur T |
President, CEO |
RSU Award |
562,500 |
$16.45 |
$9.25M |
562,500 |
| 2026-02-10 |
Hansen Gwenn |
Chief Scientific Officer |
RSU Award |
42,875 |
- |
- |
42,875 |
| 2026-02-10 |
Ring Christine |
Chief Legal Officer |
RSU Award |
42,875 |
- |
- |
42,875 |
| 2026-02-10 |
Van Houte Hans |
Chief Financial Officer |
RSU Award |
42,875 |
- |
- |
42,875 |
| 2026-02-09 |
Ring Christine |
Chief Legal Officer |
Informative Sell |
14,261 |
$16.66 |
$237.62K |
42,749 |
| 2026-02-03 |
Hansen Gwenn |
Chief Scientific Officer |
Option Exercise (Sell) |
31,333 |
$0.84 |
$26.32K |
- |
| 2026-01-30 |
Hansen Gwenn |
Chief Scientific Officer |
Option Exercise (Sell) |
3,207 |
- |
- |
- |
| 2026-01-30 |
Ring Christine |
Chief Legal Officer |
Option Exercise (Sell) |
1,925 |
- |
- |
- |
| 2026-01-30 |
Van Houte Hans |
Chief Financial Officer |
Option Exercise (Sell) |
2,887 |
- |
- |
- |
| 2026-01-20 |
Ring Christine |
Chief Legal Officer |
Option Exercise (Sell) |
3,760 |
$1.86 |
$6.99K |
8,643 |
| 2025-12-18 |
Ring Christine |
Chief Legal Officer |
Option Exercise (Sell) |
3,760 |
$1.86 |
$6.99K |
12,403 |
| 2025-11-24 |
Ring Christine |
Chief Legal Officer |
Option Exercise (Sell) |
37,600 |
$1.86 |
$69.94K |
16,163 |
| 2025-11-06 |
Dansey Roger D |
Director |
Unknown |
- |
- |
- |
- |
| 2025-11-06 |
Dansey Roger D |
Director |
RSU Award |
50,000 |
$12.52 |
$626K |
50,000 |
| 2025-11-03 |
Van Houte Hans |
Chief Financial Officer |
Informative Sell |
6,284 |
$12.56 |
$78.93K |
37,592 |
| 2025-10-30 |
Hansen Gwenn |
Chief Scientific Officer |
Option Exercise (Sell) |
3,207 |
- |
- |
3,207 |
| 2025-10-30 |
Ring Christine |
Chief Legal Officer |
Option Exercise (Sell) |
1,924 |
- |
- |
1,925 |
| 2025-10-30 |
Van Houte Hans |
Chief Financial Officer |
Option Exercise (Sell) |
2,886 |
- |
- |
2,887 |
| 2025-10-14 |
Hansen Gwenn |
Chief Scientific Officer |
RSU Award |
20,000 |
- |
- |
20,000 |
| 2025-09-17 |
Gregory Julia P |
Director |
Option Exercise |
10,750 |
$1.86 |
$20K |
10,750 |
| 2025-08-01 |
Van Houte Hans |
Chief Financial Officer |
Informative Sell |
5,402 |
$11.03 |
$59.6K |
35,512 |
| 2025-07-30 |
Ring Christine |
Chief Legal Officer |
Option Exercise |
1,924 |
- |
- |
39,242 |
| 2025-07-30 |
Van Houte Hans |
Chief Financial Officer |
Option Exercise (Sell) |
2,886 |
- |
- |
5,773 |
| 2025-05-19 |
Gregory Julia P |
Director |
RSU Award |
25,000 |
$9.51 |
$237.75K |
25,000 |
| 2025-05-19 |
Reinsdorf Judith A |
Director |
RSU Award |
25,000 |
$9.51 |
$237.75K |
25,000 |
| 2025-05-19 |
Silva Paul M |
Director |
RSU Award |
25,000 |
$9.51 |
$237.75K |
25,000 |
| 2025-05-19 |
Kunkel Lori Anne |
Director |
RSU Award |
25,000 |
$9.51 |
$237.75K |
25,000 |
| 2025-05-19 |
Baynes Roy D. |
Director |
RSU Award |
25,000 |
$9.51 |
$237.75K |
25,000 |
| 2025-05-19 |
Kapur Anil |
Director |
RSU Award |
25,000 |
$9.51 |
$237.75K |
25,000 |
| 2025-05-19 |
Lacey David L. |
Director |
RSU Award |
25,000 |
$9.51 |
$237.75K |
25,000 |
| 2025-05-19 |
Saltzman Edward C |
Director |
RSU Award |
25,000 |
$9.51 |
$237.75K |
25,000 |
| 2025-05-02 |
Van Houte Hans |
Chief Financial Officer |
Informative Sell |
6,198 |
$11.33 |
$70.24K |
33,724 |
| 2025-04-30 |
Hansen Gwenn |
Chief Scientific Officer |
Option Exercise (Sell) |
2,000 |
- |
- |
8,000 |
| 2025-04-30 |
Ring Christine |
Chief Legal Officer |
Option Exercise (Sell) |
1,924 |
- |
- |
5,773 |
| 2025-04-30 |
Van Houte Hans |
Chief Financial Officer |
Option Exercise (Sell) |
2,000 |
- |
- |
8,000 |
| 2025-03-11 |
Baynes Roy D. |
Director |
Unknown |
10,000 |
$9.25 |
$92.5K |
- |
| 2025-03-11 |
Baynes Roy D. |
Director |
RSU Award |
50,000 |
$13.90 |
$695K |
50,000 |
| 2025-03-03 |
Van Houte Hans |
Chief Financial Officer |
Informative Sell |
700 |
$15.13 |
$10.59K |
33,724 |
| 2025-02-11 |
Sands Arthur T |
President, CEO |
RSU Award |
450,000 |
$17.12 |
$7.7M |
450,000 |
| 2025-02-11 |
Hansen Gwenn |
Chief Scientific Officer |
RSU Award |
34,300 |
- |
- |
34,300 |
| 2025-02-11 |
Ring Christine |
Chief Legal Officer |
RSU Award |
34,300 |
- |
- |
34,300 |
| 2025-02-11 |
Van Houte Hans |
Chief Financial Officer |
RSU Award |
34,300 |
- |
- |
34,300 |
| 2025-01-31 |
Ring Christine |
Chief Legal Officer |
Option Exercise (Sell) |
5,537 |
$1.86 |
$10.3K |
- |
| 2025-01-30 |
Hansen Gwenn |
Chief Scientific Officer |
Option Exercise (Sell) |
2,000 |
- |
- |
10,000 |
| 2025-01-30 |
Ring Christine |
Chief Legal Officer |
Option Exercise (Sell) |
1,924 |
- |
- |
7,697 |
| 2025-01-30 |
Van Houte Hans |
Chief Financial Officer |
Option Exercise (Sell) |
2,000 |
- |
- |
10,000 |
| 2025-01-02 |
Ring Christine |
Chief Legal Officer |
Informative Sell |
5,760 |
$19.50 |
$112.29K |
28,084 |
| 2024-12-02 |
Ring Christine |
Chief Legal Officer |
Informative Sell |
5,760 |
$21.73 |
$125.16K |
28,084 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
